BY AN MCL-1-DEPENDENT MECHANISM, ALVOCIDIB POTENTIATES THE ACTIVITY OF CYTARABINE AND MITOXANTRONE WHEN ADMINISTERED IN A TIME SEQUENTIAL REGIMEN IN AML

Haws, H; Livingston, M; Kim, W; Mangelson, R; Siddiqui-Jain, A; Peterson, P; Whatcott, C; Weitman, S; Bearss, D; Warner, S

HAEMATOLOGICA, 2017; 102 ( ): 362